Imprivata Receives Frost & Sullivan 2012 North American Customer Value Enhancement Award For Speeding Adoption Of Electronic Medical Records
Company recognized for keen understanding of clinical workflows and optimization of EMRs
LEXINGTON, Mass. — May 31, 2012— Frost & Sullivan has awarded its 2012 North American Customer Value Enhancement Award to Imprivata, the leader in secure access management and collaboration for healthcare. The company was recognized for its deep understanding of clinical workflow that enables its solutions to drive electronic medical record (EMR) adoption and improve physician productivity. The designation is based on the performance and growth Imprivata has demonstrated in the EMR market, including its 2011 endorsement by the American Hospital Association (AHA), no. 1 KLAS ranking for Single Sign-On solutions, and over 40 percent annual company growth due to the successful acceleration of EMR adoption within its 900 healthcare customer base.
“Imprivata stands out from the pack by having a keen understanding of clinicians’ needs, and providing secure yet easy-to-use solutions that positively impact and streamline their workflow, ultimately leading to increased EMR adoption,” said Darshana De, senior research analyst, Frost & Sullivan. “This unique ability to provide such noted value and strong ROI for its broad customer base is why Frost & Sullivan is recognizing Imprivata with our Customer Value Enhancement Award.”
The Frost & Sullivan Award for Customer Value Enhancement is presented each year within various categories to companies that demonstrate excellence in implementing strategies that create value for customers with a focus on improving their return on the investment. Frost & Sullivan consultants conduct extensive research to determine which companies worldwide are best managing growth, innovation and leadership.
“Our team takes pride in our depth of knowledge and true understanding of both the IT and clinical needs of our customers, which results in our ability to deliver practical and valuable solutions that equally address both the security and workflow requirements,” said Omar Hussain,
Nearly $19 billion in government incentives offered by the Health Information Technology for Economic and Clinical Health (HITECH) act and established Meaningful Use requirements are pushing healthcare facilities to implement EMRs. With this strong growth, Imprivata has experienced a parallel surge in demand as healthcare facilities are seeking solutions that streamline physician access and create workflow efficiencies for the use of EMRs. By providing secure, No Click Access® to EMRs and patient health information, Imprivata is satisfying care providers and enabling its customers to adopt EMRs faster.
Frost & Sullivan cites Imprivata OneSign® Virtual Desktop Access as an industry leader due to its simple, secure access that also extends the benefits of desktop virtualization. The firm also recognized the gains made by Imprivata’s Single Sign-On solution to effectively save up to 70 hours per year per physician, which equals to 240 additional patients seen per year.
With more than 2 million users and 900 healthcare customers, Imprivata is the #1 provider of secure access solutions for healthcare, government, finance and other regulated industries. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers realize improved workflows, increased security and compliance with government regulations.
Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts, including a Strong Positive rating in Gartner’s 2011 Marketscope for ESSO, the #1 ranking in the KLAS SSO Performance report and the #1 rating in 2010 Best in KLAS and Category Leaders report. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers and serves the access security needs of customers around the world. For more information, please visit www.imprivata.com or follow us on Twitter at @Imprivata.